BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19471118)

  • 1. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.
    Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1901-4. PubMed ID: 19471118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence.
    Demidenko ZN; Shtutman M; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1896-900. PubMed ID: 19478560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes.
    Ido Y; Duranton A; Lan F; Weikel KA; Breton L; Ruderman NB
    PLoS One; 2015; 10(2):e0115341. PubMed ID: 25647160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.
    Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1883-7. PubMed ID: 19448395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
    Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
    Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth stimulation leads to cellular senescence when the cell cycle is blocked.
    Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2008 Nov; 7(21):3355-61. PubMed ID: 18948731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts.
    Faragher RG; Burton DG; Majecha P; Fong NS; Davis T; Sheerin A; Ostler EL
    Age (Dordr); 2011 Dec; 33(4):555-64. PubMed ID: 21318333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of phenotypes of cellular senescence by pan-mTOR inhibition.
    Walters HE; Deneka-Hannemann S; Cox LS
    Aging (Albany NY); 2016 Feb; 8(2):231-44. PubMed ID: 26851731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells.
    Brito PM; Devillard R; Nègre-Salvayre A; Almeida LM; Dinis TC; Salvayre R; Augé N
    Atherosclerosis; 2009 Jul; 205(1):126-34. PubMed ID: 19108833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.
    Demidenko ZN; Blagosklonny MV
    Aging (Albany NY); 2009 Dec; 1(12):1008-16. PubMed ID: 20157583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin decelerates cellular senescence.
    Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gerosuppression by pan-mTOR inhibitors.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.
    Leontieva OV; Paszkiewicz G; Demidenko ZN; Blagosklonny MV
    Cell Death Dis; 2013 Jan; 4(1):e472. PubMed ID: 23348586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin, proliferation and geroconversion to senescence.
    Blagosklonny MV
    Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.
    Darzynkiewicz Z; Zhao H; Halicka HD; Li J; Lee YS; Hsieh TC; Wu JM
    Cytometry A; 2014 May; 85(5):386-99. PubMed ID: 24677687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Inhibition Rejuvenates the Aging Gingival Fibroblasts through Alleviating Oxidative Stress.
    Xia Y; Sun M; Xie Y; Shu R
    Oxid Med Cell Longev; 2017; 2017():6292630. PubMed ID: 28804534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine suppresses gero-conversion from cell cycle arrest to senescence.
    Zhao H; Halicka HD; Li J; Darzynkiewicz Z
    Aging (Albany NY); 2013 Aug; 5(8):623-36. PubMed ID: 23974852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca(2+)- and phospholipase D-dependent and -independent pathways activate mTOR signaling.
    Ballou LM; Jiang YP; Du G; Frohman MA; Lin RZ
    FEBS Lett; 2003 Aug; 550(1-3):51-6. PubMed ID: 12935885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.